Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
Harvard University · Dana-Farber Cancer Institute · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
881
total citations
- FWCI
- 33.89
- Percentile
- 100%
- References
- 49
Citations per year
Authors
12Topics & keywords
Topics
Keywords
- Thiazolidinedione
- Rosiglitazone
- Peroxisome proliferator-activated receptor
- Endocrinology
- Phosphorylation
- Internal medicine
- Pioglitazone
- Adipogenesis
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.